Wenfei Yu - Shandong University of Traditional Chinese Medicine

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 18 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Hesperitin Prevents Non-Alcoholic Steatohepatitis by Modulating Mitochondrial Dynamics and Mitophagy Via the AMPKα-Drp1/PINK1-Parkin Signaling Pathway

Suwen Chen,Haifei Lu,Guoliang Yin,Xin Zhang,Decheng Meng,Wenfei Yu, Linya Wang,Hongshuai Liu,Fengxia Zhang

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDSno. 1 (2025)

引用0浏览0WOS引用

Diosgenin Attenuates Nonalcoholic Fatty Liver Disease Through Mtor-Mediated Inhibition of Lipid Accumulation and Inflammation

Guoliang Yin,Hongyi Liang,Yiran Cheng,Suwen Chen,Xin Zhang,Decheng Meng,Wenfei Yu,Hongshuai Liu,Chaoyuan Song,Fengxia Zhang

CHEMICO-BIOLOGICAL INTERACTIONS (2025)

引用0浏览0WOS引用

Diosgenin Alleviates Lipid Accumulation in NAFLD Through the Pathways of Ferroptosis Defensive and Executive System

Linya Wang, Hongzhuan Yu, Dongxian Wang,Guoliang Yin, Suwen Chen,Xin Zhang,Wenfei Yu,Decheng Meng,Hongshuai Liu,Wenying Jiang,Fengxia Zhang

The Journal of nutritional biochemistry (2025): 109886-109886

引用0浏览0WOS引用

The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis

Xin Zhang,Suwen Chen,Guoliang Yin,Pengpeng Liang,Yanan Feng,Wenfei Yu,Decheng Meng,Hongshuai Liu,Fengxia Zhang

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2024)

引用1浏览0WOS引用

[Research progress of traditional Chinese medicine in regulating autophagy for intervening in diabetic cardiomyopathy]

Feng-Zhao Liu, Li-Juan Zhao,Ji-Xin Li,Wen-Ru Wang, Zhen-Yu Yang, Tao Wu,Wen-Fei Yu,Yun-Sheng Xu

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medicano. 14 (2024): 3714-3724

引用0浏览0WOS引用

Diosgenin Ameliorating Non-Alcoholic Fatty Liver Disease Via Nrf2-mediated Regulation of Oxidative Stress and Ferroptosis

Xin Zhang,Guoliang Yin,Suwen Chen,Decheng Meng,Wenfei Yu,Hongshuai Liu, Linya Wang,Fengxia Zhang

DIABETES OBESITY & METABOLISMno. 12 (2024): 5745-5756

引用0浏览0WOS引用

Targeting Programmed Cell Death in Diabetic Kidney Disease: from Molecular Mechanisms to Pharmacotherapy

Fengzhao Liu, Zhenyu Yang,Jixin Li, Tao Wu, Xiangyu Li, Lijuan Zhao,Wenru Wang,Wenfei Yu, Guangheng Zhang,Yunsheng Xu

Molecular medicine (Cambridge, Mass)no. 1 (2024): 265-265

引用0浏览0WOS引用

Targeting Autophagy with Natural Products As a Potential Therapeutic Approach for Diabetic Microangiopathy

Fengzhao Liu, Lijuan Zhao, Tao Wu,Wenfei Yu,Jixin Li,Wenru Wang,Chengcheng Huang,Zhihao Diao,Yunsheng Xu

Frontiers in Pharmacology（2024）

引用1浏览0WOS引用

Effects of Different Natural Products in Patients with Non-Alcoholic Fatty Liver Disease-a Network Meta-Analysis of Randomized Controlled Trials

Hongshuai Liu,Yufei Li, Yan Jin, Xin Li,Dongxian Wang,Xiaowen Yu,Zhenyuan Jiang,Guoliang Yin,Suwen Chen,Xin Zhang,Decheng Meng,Wenfei Yu, Wenyin Jiang,Fengxia Zhang

Phytotherapy Research (2024)

引用0浏览0WOS引用

Diosgenin Attenuates Metabolic-Associated Fatty Liver Disease Through the Hepatic NLRP3 Inflammasome-Dependent Signaling Pathway

Wenfei Yu,Guoliang Yin,Suwen Chen,Xin Zhang,Decheng Meng,Linya Wang,Hongshuai Liu,Wenying Jiang,Yuqing Sun,Fengxia Zhang

International Immunopharmacology (2024): 112581-112581

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn